Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.55 - $11.25 $35,485 - $52,875
-4,700 Reduced 23.38%
15,400 $130,000
Q2 2022

Aug 15, 2022

BUY
$6.8 - $14.23 $63,920 - $133,762
9,400 Added 87.85%
20,100 $152,000
Q1 2022

May 16, 2022

SELL
$13.42 - $23.38 $206,668 - $360,052
-15,400 Reduced 59.0%
10,700 $148,000
Q4 2021

Feb 14, 2022

BUY
$12.78 - $23.74 $333,558 - $619,614
26,100 New
26,100 $620,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $288M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.